BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3103933)

  • 1. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
    Hurst JS; Slater TF; Lang J; Juergens G; Zollner H; Esterbauer H
    Chem Biol Interact; 1987 Feb; 61(2):109-24. PubMed ID: 3103933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 4-hydroxy-2,3-trans-nonenal on platelet function.
    Selley ML; McGuiness JA; Jenkin LA; Bartlett MR; Ardlie NG
    Thromb Haemost; 1988 Apr; 59(2):143-6. PubMed ID: 3133806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
    Selley ML; Bartlett MR; Czeti AL; Ardlie NG
    Atherosclerosis; 1998 Sep; 140(1):105-12. PubMed ID: 9733221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences related to the production of arachidonic acid between collagen- and thrombin-stimulated human platelets.
    Fujita M; Nakagawa Y; Osawa R; Kijima-Suda I; Setaka M; Nojima S; Tomita K
    J Biochem; 1994 Aug; 116(2):269-73. PubMed ID: 7822242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.